STATFACTS · aya

Cancer Among Adolescents and Young Adults (AYAs) (Ages 15–39)

Open original source → · Download preserved record

Source-level population statistics, not individual predictions. Different measures and subtypes are not interchangeable.

aya

name

source title

Cancer Stat Facts: Cancer Among Adolescents and Young Adults (AYAs) (Ages 15–39)

source

id: aya
name: Cancer Among Adolescents and Young Adults (AYAs) (Ages 15–39)
url: https://seer.cancer.gov/statfacts/html/aya.html
file: raw/aya.html
sha256: 51e9c80cc64853b3c3bf17ac5bacdb6ce31d206ae443b164ccba2be95381700a
bytes: 109535
retrieved at: 2026-09-09T23:18:20.018991+00:00

kind

multiple_sites

historical survival

metric

relative_survival

horizon years

estimate type

observed_published_estimate

x axis

diagnosis_year

cohort

registry: SEER 8
diagnosis years: 1975
2018
race: All races
sex: Both sexes
age range: 15
39
age adjustment: Source null
source footnote: SEER 8 5-Year Relative Survival Percent from 1975–2018, All Races, Ages 15–39, Both Sexes. Modeled trend lines were calculated from the underlying rates using the Joinpoint Survival Model Software (JPSurv).
stage: All stages

points

diagnosis year
1975
percent
70.34
diagnosis year
1976
percent
72.49
diagnosis year
1977
percent
72.84
diagnosis year
1978
percent
72.22
diagnosis year
1979
percent
72.18
diagnosis year
1980
percent
73.93
diagnosis year
1981
percent
74.07
diagnosis year
1982
percent
74.05
diagnosis year
1983
percent
72.74
diagnosis year
1984
percent
70.32
diagnosis year
1985
percent
70.38
diagnosis year
1986
percent
70.92

missing years

diagnosis year
2019
status
not_reported
source value
-
modeled value present
true
diagnosis year
2020
status
not_reported
source value
-
modeled value present
true
diagnosis year
2021
status
not_reported
source value
-
modeled value present
true
diagnosis year
2022
status
not_reported
source value
-
modeled value present
true
diagnosis year
2023
status
not_reported
source value
-
modeled value present
true
diagnosis year
2024
status
not_reported
source value
-
modeled value present
false

source table id

scrapeTable_01

confidence intervals

Source null

sample sizes

Source null

overall survival

metric

relative_survival

horizon years

percent

86.1

cohort

registry: SEER 21 (Excluding IL)
diagnosis years: 2016
2022
race: All races
sex: Both sexes
age range: 15
39
age adjustment: Source null
source footnote: Based on data from SEER 21 (Excluding IL) 2016–2022. Gray figures represent AYAs who have died from cancer within 5 years of diagnosis. Green figures represent those who have survived 5 years or more.
stage: All stages
demographic scope source: Category survival-trend footnote; pooled box source footnote retained separately

source element

statBox

stage survival

Source null

subtype survival

additional survival tables

table id
table-10
title
Source null
headers
text
Site
colspan
1
rowspan
1
text
Rate of New Cases (2019–2023)
colspan
1
rowspan
1
text
Death Rate (2020–2024)
colspan
1
rowspan
1
text
5-Year Relative Survival (%) (2016–2022)
colspan
1
rowspan
1
rows
Bladder
0.5
0.0
89.0
Bone and Joint
0.9
0.3
72.9
Brain and Other Nervous System (ONS)
2.8
0.9
72.2
Breast
12.0
1.0
87.3
Cervix
6.1
0.8
80.9
Colon and Rectum
5.6
0.9
75.7
Hodgkin Lymphoma
3.5
0.1
96.9
Kidney and Renal Pelvis
2.5
0.1
90.7
Leukemia
3.8
0.8
75.6
Liver and Intrahepatic Bile Duct
0.5
0.2
40.5
Lung and Bronchus
1.0
0.3
55.2
Melanoma of the Skin
5.4
0.2
96.3
footnotes
section id
both
table id
table-11
title
Source null
headers
text
Site
colspan
1
rowspan
1
text
Rate of New Cases (2019–2023)
colspan
1
rowspan
1
text
Death Rate (2020–2024)
colspan
1
rowspan
1
text
5-Year Relative Survival (%) (2016–2022)
colspan
1
rowspan
1
rows
Bladder
0.3
0.0
82.9
Bone and Joint
0.8
0.3
78.5
Brain and Other Nervous System (ONS)
2.4
0.7
76.8
Breast
24.2
2.1
87.3
Cervix
6.1
0.8
80.9
Colon and Rectum
5.7
0.8
78.7
Hodgkin Lymphoma
3.5
0.0
97.7
Kidney and Renal Pelvis
2.1
0.1
92.5
Leukemia
3.2
0.6
76.9
Liver and Intrahepatic Bile Duct
0.4
0.2
47.1
Lung and Bronchus
1.0
0.3
59.5
Melanoma of the Skin
7.1
0.2
97.6
footnotes
section id
female
table id
table-12
title
Source null
headers
text
Site
colspan
1
rowspan
1
text
Rate of New Cases (2019–2023)
colspan
1
rowspan
1
text
Death Rate (2020–2024)
colspan
1
rowspan
1
text
5-Year Relative Survival (%) (2016–2022)
colspan
1
rowspan
1
rows
Bladder
0.8
0.0
91.7
Bone and Joint
1.1
0.4
69.0
Brain and Other Nervous System (ONS)
3.1
1.1
68.9
Breast
0.1
0.0
83.4
Cervix
-
-
-
Colon and Rectum
5.5
1.0
72.6
Hodgkin Lymphoma
3.6
0.1
96.2
Kidney and Renal Pelvis
3.0
0.2
89.5
Leukemia
4.4
0.9
74.6
Liver and Intrahepatic Bile Duct
0.6
0.3
35.7
Lung and Bronchus
0.9
0.4
50.8
Melanoma of the Skin
3.6
0.2
93.9
footnotes
section id
male

availability

historical survival: available
overall survival: available
stage survival: not_published_on_this_page

reuse

public domain statement present: true
attribution: National Cancer Institute, SEER Cancer Stat Facts
source url: https://seer.cancer.gov/statfacts/html/aya.html

limitations

Published aggregate registry statistics; no individual-level records.
Five-year relative survival is not overall survival, a treatment effect, or an individual prognosis.
Year-of-diagnosis trends are not survival curves across follow-up time.
Null age_range means no explicit age subgroup in the source; it does not mean age zero.
No survival age adjustment is asserted unless explicitly documented.
Do not join pooled current estimates onto annual historical trends: registry coverage and cohorts differ.

Preserved source evidence · Not medical advice